Profile for Proteostasis Therapeutics Inc. (PTI)

$ 1.31 r      0.01 (+0.77%) Volume: 2.56m 4:00 PM EDT May 29, 2020
After Hours:  $ 1.37   0.06 (+4.58%) Volume: 8.12k 6:25 PM EDT May 29, 2020
Business Description:
Proteostasis Therapeutics Inc operates in the healthcare sector of United States. Its business involves the discovery and development of therapeutics to correct the imbalance of the protein biosynthesis process.
Address: 80 Guest Street, Suite 500, 5th Floor, Boston, MA, USA, 02135
Telephone: +1 617 225-0096 Website:
Facsimile: N/A Email: [email protected]
CEO: Meenu Chhabra
Employees: 44 Market Cap: 68.31m
Issue Type: CS
Auditor: PricewaterhouseCoopers LLP
Last Audit: Unqualified Opinion with Explanation
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 1445283
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Biological Products, Except Diagnostic Substances (2836)